DCT

1:24-cv-01524

Board Of Regents Of University Of Texas System v. Alnylam Pharma Inc

General
Filed
12/12/24
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
SourcePACER
Nature of Suit830 Patent
Judge
Period
PO Win Rate
02/05/25 - 12/16/25
63%
01/10/25 - 02/05/25
18%
MagistrateMark P. Lane
Plaintiff
Party
Attorney
Defendant
Party